SCHEMBL8317781

SCHEMBL8317781

COC(Cc1ccc(OCc2ccccc2)cc1)c1ccc(/C=C/C(=O)O)cc1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.57
BACE1 P56817 4/20 0.57
MAOB P27338 2/20 0.56
MMP1 P03956 2/20 0.54
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
KDM4E B2RXH2 2/20 0.52
ALDH1A1 P00352 1/20 0.52
PKM P14618 1/20 0.52
ABCG2 Q9UNQ0 1/20 0.52
MEN1 O00255 1/20 0.52
TP53 P04637 1/20 0.52
MAPT P10636 1/20 0.52
KMT2A Q03164 1/20 0.52
APP P05067 1/20 0.52
SLC5A1 P13866 1/20 0.50
SLC5A2 P31639 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8317320 0.91 GSK3B (0.58) GSK3BBACE1MAOBMMP1NPC1
SCHEMBL8320471 0.89 GSK3B (0.52) GSK3BBACE1MAOBMMP1NPC1
SCHEMBL8317289 0.89 MMP1 (0.55) GSK3BBACE1MAOBMMP1NPC1
SCHEMBL527827 0.83 GSK3B (0.80) GSK3BBACE1MAOBNPC1RAB9A
SCHEMBL8740053 0.83 GSK3B (0.80) GSK3BBACE1MAOBNPC1RAB9A
SCHEMBL527828 0.83 GSK3B (0.80) GSK3BBACE1MAOBNPC1RAB9A
Hydrochloric Acid SCHEMBL7054738 0.82 GSK3B (0.78) GSK3BBACE1MAOBNPC1RAB9A
SCHEMBL5947456 0.80 KDM4E (0.71) GSK3BBACE1MAOBNPC1RAB9A
SCHEMBL5947453 0.80 KDM4E (0.71) GSK3BBACE1MAOBNPC1RAB9A
SCHEMBL15239146 0.79 THRB (0.73) GSK3BBACE1MAOBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004071401-A2 HYDROXAMIC ACID DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS (HDCA) FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-26 WO disclosed